ReviewCurrent cancer drug targets2009

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.

Todd M Morgan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.